[1] [1] BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.

[3] [3] CHO S J, CHOI I J, KOOK M C, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems[J]. Aliment Pharmacol Ther, 2013, 38(10): 1292-1302.

[4] [4] LEE J W J, ZHU F, SRIVASTAVA S, et al. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)[J]. Gut, 2022, 71(5): 854-863.

[5] [5] BANKS M, GRAHAM D, JANSEN M, et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma[J]. Gut, 2019, 68(9): 1545-1575.

[6] [6] HUANG Y, CHEN J N, GUO Y X, et al. Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study[J]. J Clin Pathol, 2025, 78(2): 117-122.

[7] [7] PIMENTEL-NUNES P, LIBNIO D, LAGE J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions[J]. Endoscopy, 2016, 48(8): 723-730.

[8] [8] FANG S S, FU Y H, DU S J, et al. The role of the endoscopic grading of gastric intestinal metaplasia in assessing gastric cancer risk: a systematic review and meta-analysis[J]. Front Oncol, 2022, 12: 1018248.

[10] [10] JI R, LIU J, ZHANG M M, et al. Optical enhancement imaging versus acetic acid for detecting gastric intestinal metaplasia: a randomized, comparative trial[J]. Dig Liver Dis, 2020, 52(6): 651-657.

[11] [11] SHA J, WANG P, ZHU B L, et al. Acetic acid enhanced narrow band imaging for the diagnosis of gastric intestinal metaplasia[J]. PLoS One, 2017, 12(1): e0170957.

[12] [12] SONG K H, HWANG J A, KIM S M, et al. Acetic acid chromoendoscopy for determining the extent of gastric intestinal metaplasia[J]. Gastrointest Endosc, 2017, 85(2): 349-356.

[13] [13] TORUN C, YAVUZ A, AKAN K, et al. Comparison of the diagnostic accuracy of the updated Sydney system and single biopsy[J]. Saudi J Gastroenterol, 2022, 28(6): 441-447.

[14] [14] ZHANG G P, ZHENG J, ZHENG L F, et al. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology[J]. Scand J Gastroenterol, 2021, 56(1): 103-110.

[15] [15] CASTRO R, RODRIGUEZ M, LIBNIO D, et al. Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach[J]. Scand J Gastroenterol, 2019, 54(11): 1301-1305.

[16] [16] KAWAMURA M, UEDO N, YAO K S, et al. Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia[J]. J Gastroenterol Hepatol, 2024, 39(9): 1910-1916.

[17] [17] DESAI M, BOREGOWDA U, SRINIVASAN S, et al. Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia: a systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2021, 36(8): 2038-2046.

[18] [18] GUELRUD M, HERRERA I. Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy[J]. Gastrointest Endosc, 1998, 47(6): 512-515.

[19] [19] KURTCEHAJIC A, ZEREM E, BOKUN T, et al. Could near focus endoscopy, narrow-band imaging, and acetic acid improve the visualization of microscopic features of stomach mucosa?[J]. World J Gastrointest Endosc, 2024, 16(3): 157-167.

[21] [21] NA H K, CHOI K D, PARK Y S, et al. Endoscopic scoring system for gastric atrophy and intestinal metaplasia: correlation with OLGA and OLGIM staging: a single-center prospective pilot study in Korea[J]. Scand J Gastroenterol, 2022, 57(9): 1097-1104.